| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017620 |
| Receipt No. | R000019285 |
| Official scientific title of the study | Search for the ocular surface biomarker in the Sjogren's syndrome dry eye patients treated with rebamipide ophthalmic solution. |
| Date of disclosure of the study information | 2015/05/20 |
| Last modified on | 2018/11/20 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Search for the ocular surface biomarker in the Sjogren's syndrome dry eye patients treated with rebamipide ophthalmic solution. | |
| Title of the study (Brief title) | Search for the ocular surface biomarker in dry eye patients treated with rebamipide ophthalmic solution. | |
| Region |
|
|
| Condition | ||
| Condition | Dry eye | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To search for ocular surface biomarker to determine the therapeutic solution in patients with Sjogren syndrome and dry eye. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase IV |
| Assessment | |
| Primary outcomes | Serial investigation of the therapeutic effect of rebamipide ophthalmic solution using the ocular surface biomarker in dry eye disease. |
| Key secondary outcomes | Search of the ocular surface biomarker in the treatment of dry eye disease. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | SPDEF mRNA expression levels on ocular surface: more than 6.0. | |
| Interventions/Control_2 | SPDEF mRNA expression levels on ocular surface: less than 6.0 more than 1.7. | |
| Interventions/Control_3 | SPDEF mRNA expression levels on ocular surface: Less than 1.7. | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Sjogren syndrome dry eye patient
1) Male or female of age of 20 years or older 2) Patients who provided written informed consent for participating in this study. 3) Patients who are diagnosed as Sjogren syndrome dry eye according to both Sjogren syndrome diagnostic criteria and the Japan dry eye diagnostic criteria in 2006. 4) The patient who has either sensation of xerosis or foreign body sensation as main complication, and has 50 points or more of VAS score of the main symptom. |
|||
| Key exclusion criteria | Sjogren syndrome dry eye patient
1) Patients with anterior segment disease, including blepharitis, lagophthalmos, blepharospasm, iritis and conjunctivochalasis other than dry eye (History is excluded). 2) Patients who cannot discontinue eye drops (include all eye drops such as prescribed drug and OTC medicine) except for the study drug or the control drug from the study initiation until the end of study treatment or who expect to use those drugs 3) Patients with punctal plug or patients whose punctal plug fell off within three months prior to the study drug initiation examination. 4) Patients with a history of surgical punctual occlusion are also excluded. 5) Patients with a history of surgery of the ocular surface within 12 months. 6) Patients with a history of intraocular surgery within three months prior to the study drug initiation examination. 7) Contact lens wearer. 8) Patients with the change of the systemic medicament during study period. 9) Patients who have difficulty in sampling. 10) Patients that a study supervisor or a study partaker judged participation in this study to be inappropriate. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Jun Shoji |
| Organization | Nihon University School of Medicine |
| Division name | Division of Ophthalmology, Department of Visual Sciences |
| Address | Oyaguchikamimachi 30-1, Itabashi-ku, Tokyo, Japan |
| TEL | 03-3972-8111 |
| shojig3589eye@athena.ocn.ne.jp | |
| Public contact | |
| Name of contact person | Jun Shoji |
| Organization | Nihon University School of Medicine |
| Division name | Division of Ophthalmology, Department of Visual Sciences |
| Address | Oyaguchikamimachi 30-1, Itabashi-ku, Tokyo, Japan |
| TEL | 03-3972-8111 |
| Homepage URL | |
| shojig3589eye@athena.ocn.ne.jp | |
| Sponsor | |
| Institute | Division of Ophthalmology, Department of Visual Sciences, Nihon University School of Medicine. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Otsuka Pharmaceutical Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 日本大学医学部付属板橋病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019285 |